Crystal Rock Capital Management Boston Scientific Corp Transaction History
Crystal Rock Capital Management
- $164 Million
- Q2 2025
A detailed history of Crystal Rock Capital Management transactions in Boston Scientific Corp stock. As of the latest transaction made, Crystal Rock Capital Management holds 64,770 shares of BSX stock, worth $6.52 Million. This represents 4.24% of its overall portfolio holdings.
Number of Shares
64,770
Previous 69,320
6.56%
Holding current value
$6.52 Million
Previous $6.99 Million
0.53%
% of portfolio
4.24%
Previous 4.86%
Shares
14 transactions
Others Institutions Holding BSX
# of Institutions
1,934Shares Held
1.27BCall Options Held
9.59MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA137MShares$13.8 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY126MShares$12.7 Billion0.22% of portfolio
-
State Street Corp Boston, MA65.2MShares$6.57 Billion0.27% of portfolio
-
Primecap Management CO Pasadena, CA34.7MShares$3.49 Billion3.04% of portfolio
-
Bank Of America Corp Charlotte, NC33.8MShares$3.41 Billion0.27% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $144B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...